Parexel’s Peyton Howell Receives Prestigious PharmaVoice Red Jacket

Industry luminary receives PharmaVoice’s highest honor, joining elite group of life sciences industry’s most inspiring leaders

/EIN News/ — BOSTON and DURHAM, North Carolina, Sept. 15, 2022 (GLOBE NEWSWIRE) — Parexela leading global clinical research organization (CRO) focused on developing and delivering innovative new therapies to advance patient health, today announced that Peyton Howell, Chief Operating and Growth Officer, received PharmaVoice’s highest honor as 2022 Red coat honored. This prestigious award recognizes an elite group of leaders considered to be the most inspiring in the life sciences industry.

“In our challenging day-to-day work, it is visionary and empathetic leaders like Peyton Howell who drive us to consistently deliver on our commitments to our patients, customers and colleagues,” said Jamie Macdonald, President and CEO of Parexel. “His energy sparks transformation by encouraging strategic thinking, innovation and action. Peyton has a deep belief and dedication to developing diverse and inclusive teams and empowering them to meet the needs of our patients and clients. I am extremely proud to have him on the Parexel team.

Mrs. Howell Red coat honor and recognition twice as PharmaVoice 100 reflects her 26 years of innovative leadership in the healthcare industry, including the last four at Parexel where she has been instrumental in the company’s transformation and growth strategy – leading the organization’s strategic direction on patients, culture and diversity, equity and inclusion. The Red coat honor highlights its lasting impact on the healthcare industry through our Parexel Patients-First corporate core value and shows how to work creatively and diligently to better serve patients around the world.

Introduced in 2014 by Pharma Voice, the Red coat awards have been created to honor a distinguished group of industry leaders who have been lauded by their colleagues and peers on numerous occasions as PharmaVoice 100 recipients. Red Jacket winners are selected for their inspirational qualities, persistence of vision, and transformative leadership to create better health outcomes for all.

To learn more about the Red Jacket 2022 laureates, visit

About Parexel
One of the world’s largest clinical research organisations, Parexel supports the development of innovative new medicines to improve patient health. We provide services to help life science and biopharmaceutical customers around the world turn scientific discoveries into new treatments. From decentralized clinical trials to regulatory advisory services to leveraging real-world insights, our therapeutic, technical and functional capability is underpinned by a deep belief in what we do. For more information, visit and follow us on LinkedIn, Twitter, and Instagram.

Lori Preuit Dorer
+1 513 496 8121
[email protected]

Danaka Williams
+1 984 298 4207
[email protected]

main logo